102460 — Reyon Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩253bn
- KR₩460bn
- KR₩151bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 5,940 | 3,844 | 5,537 | 7,434 | 3,583 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | -1,954 | -2,394 | -2,271 | -2,504 | 2,412 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -19,834 | -1,416 | 3,753 | -734 | -2,132 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -12,184 | 4,599 | 11,685 | 8,729 | 8,645 |
Capital Expenditures | -51,380 | -52,424 | -116,997 | -63,133 | -28,872 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 84,278 | 22,829 | 2,315 | 10,569 | 20,133 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 32,898 | -29,594 | -114,682 | -52,564 | -8,739 |
Financing Cash Flow Items | -49.6 | -45.3 | -9.23 | — | -3.83 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -23,668 | 31,392 | 157,576 | -6,767 | 8,153 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2,954 | 6,371 | 54,544 | -50,691 | 8,058 |